TARSUS PHARMACEUTICALS INC. - COMMON STOCK

Tarsus to Present at Upcoming Investor Conferences

09 Mar 2022 16:00:00 By Nasdaq GlobeNewswire

Tarsus to Host Eye Care Leaders Webcast on Unmet Needs in Demodex Blepharitis and Potential of TP-03

02 Feb 2022 15:30:00 By Nasdaq GlobeNewswire

Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility

02 Feb 2022 06:00:00 By Nasdaq GlobeNewswire

Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors

04 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Tarsus to Participate at Upcoming Virtual Investor Conferences

23 Nov 2021 15:30:00 By Nasdaq GlobeNewswire

Tarsus to Participate in the Virtual Jefferies London Healthcare Conference 2021

10 Nov 2021 15:30:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Achievements

09 Nov 2021 15:05:02 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Presents Data from Two Pioneering Studies on the Prevalence and Impact of Demodex Blepharitis at the American Academy of Optometry 2021 Annual Meeting

04 Nov 2021 08:45:00 By Nasdaq GlobeNewswire

Tarsus to Participate in the Virtual Credit Suisse 30th Annual Healthcare Conference

02 Nov 2021 16:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical and Healthcare Industry Leader Rosemary A. Crane to Board of Directors

12 Aug 2021 08:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates

04 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021

24 Jul 2021 17:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference

07 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Participate in the Raymond James 2021 Human Health Innovation Conference

22 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 for the Treatment of Demodex Blepharitis

21 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis

18 Jun 2021 15:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease

16 Jun 2021 15:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual Healthcare Conference

24 May 2021 15:05:00 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business and Clinical Updates

11 May 2021 15:05:01 By Nasdaq GlobeNewswire

Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 Trial Evaluating the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

06 May 2021 15:05:01 By Nasdaq GlobeNewswire